Back to Search

CAROL BOERSMA, M.D.

M.D.

Pediatrics Physician

NPI: 1740286509Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

0101238260(VA)

Research & Publications (12)

Odynophagia.
PMID 17579111·Clin Pediatr (Phila)·2007
5-case
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.
PMID 18563949·Pharmacoeconomics·2008
1-meta
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
PMID 18241288·Br J Clin Pharmacol·2008
8-other
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
PMID 17210586·Nephrol Dial Transplant·2008
8-other
An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
PMID 17697915·Clin Ther·2007
4-observational
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
PMID 16750458·Clin Ther·2006
8-other
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
PMID 16761901·Pharmacoeconomics·2006
6-review
Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands.
PMID 16696808·Aliment Pharmacol Ther·2006
8-other
Adherence of pharmacoeconomic studies to national guidelines in the Netherlands.
PMID 16341742·Pharm World Sci·2005
4-observational
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands.
PMID 16309337·Appl Health Econ Health Policy·2005
8-other
Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
PMID 10809227·Mol Endocrinol·2000
4-observational
Estrogen receptors alpha and beta: two receptors of a kind?
PMID 10702625·Curr Med Chem·2000
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
900 RIO EAST CT, STE. A
CHARLOTTESVILLE, VA 22901

Location

Practice Location

900 RIO EAST CT, CHARLOTTESVILLE, VA
(434) 975-7777

Quick Facts

NPI
1740286509
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
12

Are you this provider?

Claim Your Profile